Insider trading

Period: 120 months Stock: VRTX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

738 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

738 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

738 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

738 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
738 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
738 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

738 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
12 Jun 2024
Bozic Carmen EVP and CMO
Sold on a plan
$1.09M 2,280 at 478.00
6.6%
Planned (10b5-1)
3 Jun 2024
WAGNER CHARLES F JR EVP & Chief Financial Officer
Sold on a plan
$1.50M 3,250 at 460.00
6.5%
Planned (10b5-1)
3 Jun 2024
Tatsis Ourania EVP, Chief Reg. & Quality Off.
Sold on a plan
$1.00M 2,175 at 460.00
4.2%
Planned (10b5-1)
31 May 2024
Tatsis Ourania EVP, Chief Reg. & Quality Off.
Sold on a plan
$1.00M 2,250 at 445.00
4.2%
Planned (10b5-1)
30 May 2024
Tatsis Ourania EVP, Chief Reg. & Quality Off.
Sold on a plan
$1.03M 2,350 at 439.11
4.2%
Planned (10b5-1)
29 May 2024
Bozic Carmen EVP and CMO
Sold on a plan
$1.02M 2,280 at 445.56
6.2%
Planned (10b5-1)
28 May 2024
WAGNER CHARLES F JR EVP & Chief Financial Officer
Sold on a plan
$1.48M 3,250 at 454.79
6.1%
Planned (10b5-1)
24 May 2024
Kewalramani Reshma CEO & President
Sold on a plan
$715.21K 1,565 at 457.00
1.3%
Planned (10b5-1)
22 May 2024
SACHS BRUCE I Director
Sold on a plan
$3.17M 7,073 at 448.00
15.0%
Planned (10b5-1)
20 May 2024
Kewalramani Reshma CEO & President
Sold on a plan
$6.80M 15,202 at 447.00
11.1%
Planned (10b5-1)
15 May 2024
Sold on a plan
$29.73K 69 at 430.93
0.1%
Planned (10b5-1)
15 May 2024
ALTSHULER DAVID EVP, Chief Scientific Officer
Sold on a plan
$23.27K 54 at 430.93
0.2%
Planned (10b5-1)
15 May 2024
Sachdev Amit EVP Chief Patient & Ext Af Off
Sold on a plan
$13.79K 32 at 430.93
0.1%
Planned (10b5-1)
2 May 2024
Sold on a plan
$188.18K 467 at 402.95
9.5%
Planned (10b5-1)
2 Apr 2024
Ambrose Kristen SVP & Chief Accounting Officer
Sold on a plan
$100.56K 240 at 419.00
3.1%
Planned (10b5-1)
26 Feb 2024
Sold on a plan
$2.14M 5,034 at 425.70
9.2%
Planned (10b5-1)
26 Feb 2024
ALTSHULER DAVID EVP, Global Research and CSO
Sold on a plan
$1.80M 4,239 at 425.70
14.1%
Planned (10b5-1)
26 Feb 2024
Sachdev Amit EVP Chief Patient & Ext Af Off
Sold on a plan
$1.28M 3,004 at 425.70
5.2%
Planned (10b5-1)
26 Feb 2024
Ambrose Kristen SVP & Chief Accounting Officer
Sold on a plan
$375.89K 883 at 425.70
10.0%
Planned (10b5-1)
26 Feb 2024
Atkinson Edward Morrow III EVP, Chief Technical Ops. Off.
Sold on a plan
$375.89K 883 at 425.70
5.2%
Planned (10b5-1)
26 Feb 2024
Tatsis Ourania EVP, Chief Reg. & Quality Off.
Sold on a plan
$150.70K 354 at 425.70
0.6%
Planned (10b5-1)
21 Feb 2024
Sold on a plan
$1.52M 3,603 at 421.77
5.7%
Planned (10b5-1)
21 Feb 2024
Sachdev Amit EVP Chief Patient & Ext Af Off
Sold on a plan
$1.35M 3,191 at 421.77
5.0%
Planned (10b5-1)
21 Feb 2024
ALTSHULER DAVID EVP, Global Research and CSO
Sold on a plan
$1.27M 3,002 at 421.77
8.1%
Planned (10b5-1)
21 Feb 2024
Atkinson Edward Morrow III EVP, Chief Technical Ops. Off.
Sold on a plan
$506.55K 1,201 at 421.77
6.1%
Planned (10b5-1)
21 Feb 2024
Tatsis Ourania EVP, Chief Reg. & Quality Off.
Sold on a plan
$151.84K 360 at 421.77
0.6%
Planned (10b5-1)
20 Feb 2024
Sold on a plan
$2.02M 4,804 at 420.79
7.1%
Planned (10b5-1)
20 Feb 2024
Sachdev Amit EVP Chief Patient & Ext Af Off
Sold on a plan
$1.79M 4,254 at 420.79
6.2%
Planned (10b5-1)
20 Feb 2024
ALTSHULER DAVID EVP, Global Research and CSO
Sold on a plan
$1.68M 4,002 at 420.79
9.8%
Planned (10b5-1)
20 Feb 2024
Atkinson Edward Morrow III EVP, Chief Technical Ops. Off.
Sold on a plan
$337.05K 801 at 420.79
3.9%
Planned (10b5-1)
20 Feb 2024
Tatsis Ourania EVP, Chief Reg. & Quality Off.
Sold on a plan
$201.98K 480 at 420.79
0.8%
Planned (10b5-1)
15 Feb 2024
LEIDEN JEFFREY M Executive Chairman
Sold on a plan
$1.95M 4,655 at 419.16
20.6%
Planned (10b5-1)
14 Feb 2024
LEIDEN JEFFREY M Executive Chairman
Sold on a plan
$1.83M 4,356 at 419.04
16.2%
Planned (10b5-1)
13 Feb 2024
LEIDEN JEFFREY M Executive Chairman
Sold on a plan
$308.90K 737 at 419.13
2.7%
Planned (10b5-1)
12 Feb 2024
Sold on a plan
$1.80M 4,295 at 420.24
5.4%
Planned (10b5-1)
12 Feb 2024
Sachdev Amit EVP Chief Patient & Ext Af Off
Sold on a plan
$1.35M 3,222 at 420.24
4.2%
Planned (10b5-1)
12 Feb 2024
ALTSHULER DAVID EVP, Global Research and CSO
Sold on a plan
$1.32M 3,145 at 420.24
6.2%
Planned (10b5-1)
12 Feb 2024
LEIDEN JEFFREY M Executive Chairman
Sold on a plan 2×
$1.11M 2,656 at 419.51
8.8%
Planned (10b5-1)
12 Feb 2024
Biller Jonathan EVP and Chief Legal Officer
Sold on a plan
$727.82K 1,738 at 418.77
8.7%
Planned (10b5-1)
12 Feb 2024
Ambrose Kristen SVP & Chief Accounting Officer
Sold on a plan
$577.41K 1,374 at 420.24
12.4%
Planned (10b5-1)
12 Feb 2024
Atkinson Edward Morrow III EVP, Chief Technical Ops. Off.
Sold on a plan
$383.68K 913 at 420.24
3.8%
Planned (10b5-1)
12 Feb 2024
Tatsis Ourania EVP, Chief Reg. & Quality Off.
Sold on a plan
$131.96K 314 at 420.24
0.5%
Planned (10b5-1)
8 Jan 2024
LEIDEN JEFFREY M Executive Chairman
Sold on a plan
$2.79M 6,648 at 419.07
73.3%
Sold half or more
2 Jan 2024
WAGNER CHARLES F JR EVP & Chief Financial Officer
Sold on a plan
$1.22M 3,000 at 405.00
6.4%
Planned (10b5-1)
15 Dec 2023
Kewalramani Reshma CEO & President
Sold on a plan
$6.97M 17,135 at 407.00
13.6%
Planned (10b5-1)
13 Dec 2023
LEIDEN JEFFREY M Executive Chairman
Sold on a plan 2×
$5.33M 13,354 at 399.42
59.5%
Sold half or more
13 Dec 2023
Sold on a plan
$3.43M 8,603 at 399.00
13.2%
Planned (10b5-1)
13 Dec 2023
Kewalramani Reshma CEO & President
Sold on a plan
$2.02M 5,098 at 397.00
4.5%
Planned (10b5-1)
20 Nov 2023
WAGNER CHARLES F JR EVP & Chief Financial Officer
Sold on a plan
$1.05M 3,000 at 349.88
6.0%
Planned (10b5-1)
15 Nov 2023
Sachdev Amit EVP Chief Patient & Ext Af Off
Sold on a plan
$12.95K 35 at 369.92
0.1%
Planned (10b5-1)
Showing 101–150 of 738. ← Newer Page 3 of 15 Older →